Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2025-12-25 @ 8:27 PM
NCT ID: NCT03382769
Description: All Serious, and Other (Not Including Serious) Adverse Events were not monitored/assessed although there was 1 subject enrolled and withdrawn due to not meeting candidacy requirements and study was terminated due to COVID 19.
Frequency Threshold: 0
Time Frame: None
Study: NCT03382769
Study Brief: Hearing Loss in Older Adults Study
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Group A (Immediate Cochlear Implantation) Group A will consist of 30 individuals who are candidates for cochlear implantation. They will be unilaterally implanted immediately after initial study testing has been completed and then be followed for 12 months after device activation. Cochlear implantation: Unilateral implantation with a commercially approved Nucleus cochlear implant 0 None 0 0 0 0 View
Group B (Delayed Cochlear Implantation) Group B will consist of 30 individuals who are candidates for cochlear implantation. They will continue to wear hearing aids after enrolling in the study and then be unilaterally implanted 6 months after enrollment and followed for 6 more months after device activation. Cochlear implantation: Unilateral implantation with a commercially approved Nucleus cochlear implant 0 None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):